BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu M, Huang H, Xiong Y, Peng B, Zhou Z, Wang D, Yang X. Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature. Oncol Lett 2014;8:291-4. [PMID: 24959263 DOI: 10.3892/ol.2014.2087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Zheng YF, Ge W, Xu HL, Cao DD, Liu L, Ming PP, Li CH, Xu XM, Tao WP, Tao ZZ. Endostar enhances the antitumor effects of radiation by affecting energy metabolism and alleviating the tumor microenvironment in a Lewis lung carcinoma mouse model. Oncol Lett 2015;10:3067-72. [PMID: 26722291 DOI: 10.3892/ol.2015.3679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Han X, Wang Z, Hu B, Xu J. Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma. Oncol Lett 2017;14:6604-10. [PMID: 29163691 DOI: 10.3892/ol.2017.7017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Seyedin SN, Gannon MK, Plichta KA, Abushahin L, Berg DJ, Arshava EV, Parekh KR, Keech JC, Caster JM, Welsh JW, Allen BG. Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma. Front Oncol 2020;10:1311. [PMID: 32850412 DOI: 10.3389/fonc.2020.01311] [Reference Citation Analysis]
4 Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther 2020;5:229. [PMID: 33028804 DOI: 10.1038/s41392-020-00323-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
5 Hall TM, Tétreault MP, Hamilton KE, Whelan KA. Autophagy as a cytoprotective mechanism in esophageal squamous cell carcinoma. Curr Opin Pharmacol 2018;41:12-9. [PMID: 29677645 DOI: 10.1016/j.coph.2018.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Saxena R, Klochkova A, Murray MG, Kabir MF, Samad S, Beccari T, Gang J, Patel K, Hamilton KE, Whelan KA. Roles for Autophagy in Esophageal Carcinogenesis: Implications for Improving Patient Outcomes. Cancers (Basel) 2019;11:E1697. [PMID: 31683722 DOI: 10.3390/cancers11111697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
7 Tantai JC, Zhang Y, Zhao H. Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling. Mol Med Rep 2016;13:1097-104. [PMID: 26647768 DOI: 10.3892/mmr.2015.4659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
8 Shan GP, Wang BB, Zheng P, Du FL, Yang YW. Efficacy and Safety of Chemotherapy Combined with Stereotactic Radiotherapy in the Treatment of Nasopharyngeal Carcinoma. Med Sci Monit 2017;23:5630-6. [PMID: 29176539 DOI: 10.12659/msm.903903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Verma R, Sattar RSA, Nimisha, Apurva, Kumar A, Sharma AK, Sumi MP, Ahmad E, Ali A, Mahajan B, Saluja SS. Cross-talk between next generation sequencing methodologies to identify genomic signatures of esophageal cancer. Crit Rev Oncol Hematol 2021;162:103348. [PMID: 33961993 DOI: 10.1016/j.critrevonc.2021.103348] [Reference Citation Analysis]
10 Huang H, Zhang C, Wang X, Shao J, Chen C, Li H, Ju C, He J, Gu H, Xia D. Overcoming Hypoxia-Restrained Radiotherapy Using an Erythrocyte-Inspired and Glucose-Activatable Platform. Nano Lett 2020;20:4211-9. [DOI: 10.1021/acs.nanolett.0c00650] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
11 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Reference Citation Analysis]